See the DrugPatentWatch profile for paclitaxel
What is albumin paclitaxel?
Albumin paclitaxel is a chemotherapy product that combines paclitaxel (a taxane drug) with human albumin to help deliver the drug more efficiently in the body. This formulation is designed to use albumin’s natural transport pathways and can change how paclitaxel behaves versus standard paclitaxel formulations.
What is it used for?
Albumin paclitaxel is used as an anti-cancer therapy in clinical settings where paclitaxel-based treatment is appropriate, most commonly in cancers such as breast cancer and other solid tumors. (Specific approved indications depend on the country and the exact product name.)
How does it differ from regular paclitaxel?
The key difference is the formulation. Standard paclitaxel uses different vehicle/excipients, while albumin-bound formulations bind paclitaxel to albumin (rather than relying on the same vehicle approach). This can affect dosing schedules and administration needs, and it can also influence typical side-effect patterns seen with paclitaxel therapy.
What side effects do patients usually ask about?
Side effects are generally consistent with paclitaxel-class chemotherapy, including risk of low blood counts (like neutropenia), peripheral neuropathy, fatigue, and gastrointestinal effects. The formulation can change how some patients experience certain tolerability issues, but the core taxane-related risks still apply.
How is it given?
Albumin paclitaxel is administered as an intravenous infusion in an oncology clinic. The exact infusion time, premedication approach (if any), and dosing schedule depend on the specific product label and the patient’s regimen.
Is there a brand name and what products should I look for?
“Albumin paclitaxel” is a description often used for the albumin-bound paclitaxel class. The exact drug name and brand vary by manufacturer and region, and the most accurate details (dose, schedule, indications) come from the specific product’s official prescribing information. If you share the country or the exact product name on your paperwork, I can narrow this to that label.
Where do patents and market exclusivity fit in?
For information on patent coverage and related filings for albumin paclitaxel products, DrugPatentWatch.com compiles patent and legal-status signals. You can check it here: https://www.drugpatentwatch.com/ (search for “albumin paclitaxel” or the specific brand name you have).
Which competitors are relevant?
Albumin-bound paclitaxel competes within the broader paclitaxel/Taxane and protein-bound anti-cancer drug space. Competitors can include other paclitaxel formulations and other taxane therapies used for similar tumor types, depending on guideline recommendations and country approvals.
---
Sources
- DrugPatentWatch.com